Range
26.16 - 27.39
Vol / Avg.
503.5K/826.8K
Div / Yield
-
52 Wk
22 - 45.44
Mkt Cap
3.2B
Payout Ratio
-
Open
26.7
P/E
-
EPS
-0.96
Shares
118.4M
Outstanding
118.4M
Total Float
94.7M
Sector: Health Care.Industry: Biotechnology
Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-24
REV
Q3 2021Est.ActualSurprise
EPS-0.860-0.960 -0.1000
REV49.230M46.757M-2.473M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Insmed Questions & Anwsers

Q

How do I buy Insmed (INSM) stock?

A

You can purchase shares of Insmed (NASDAQ: INSM) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Insmed (INSM) stock?

A

The latest price target for Insmed (NASDAQ: INSM) was reported by Cantor Fitzgerald on October 8, 2021. The analyst firm set a price target for 60.00 expecting INSM to rise to within 12 months (a possible 122.55% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Insmed (INSM)?

A

The stock price for Insmed (NASDAQ: INSM) is $26.96 last updated Thu Dec 02 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Insmed (INSM) pay a dividend?

A

There are no upcoming dividends for Insmed.

Q

When is Insmed (NASDAQ:INSM) reporting earnings?

A

Insmed’s $Q4 earnings are confirmed for after-market on February 24, 2022.

Q

Is Insmed (INSM) going to split?

A

There is no upcoming split for Insmed.

Q

What sector and industry does Insmed (INSM) operate in?

A

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.